Cargando…
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
Cabazitaxel provided a survival advantage compared with mitoxantrone in patients with castration-resistant prostate cancer refractory to docetaxel. Grade 3 to 4 (G3–4) neutropenia and febrile neutropenia were relatively frequent in the registrative XRP6258 Plus Prednisone Compared to Mitoxantrone Pl...
Autores principales: | Di Lorenzo, Giuseppe, Bracarda, Sergio, Gasparro, Donatello, Gernone, Angela, Messina, Caterina, Zagonel, Vittorina, Puglia, Livio, Bosso, Davide, Dondi, Davide, Sonpavde, Guru, Lucarelli, Giuseppe, De Placido, Sabino, Buonerba, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718232/ https://www.ncbi.nlm.nih.gov/pubmed/26765406 http://dx.doi.org/10.1097/MD.0000000000002299 |
Ejemplares similares
-
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2015) -
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017) -
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience
por: Ferro, Matteo, et al.
Publicado: (2015) -
Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report
por: Hashimoto, Mamoru, et al.
Publicado: (2019) -
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)